However, in some instances, particularly for UNC13A and ELAVL3, CE expression was significantly increased in AD compared to controls, which may be related to a modest increase in pTDP-43 levels by immunoassay in AD cases and could explain the higher levels of CE observed in AD+LATE. Here, ELAVL3 is linked to Alzheimer disease.